Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | Methyl 3-benzyloxy-7-ethoxycarbonyl-5-methyl-4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxylate | HCID 68951392 | — |
| Solvent | MeOH tetrahydrofuran | HCID 21899815 | — |
| Product | HCID 68954276 | HCID 68954276 | — |
Reaction Steps
To a solution of methyl 3-benzyloxy-7-ethoxycarbonyl-5-methyl-4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxylate (195 mg, 0.503 mmol) in MeOH/THF (0.5 mL) was added aqueous 1N NaOH (554 μL, 0.554 mmol). The mixture was stirred for 1 hour and quenched by the addition aqueous 3N HCl (170 μL). Purification by reverse phase chromatography on a C-18 column using a gradient elution of 95-5% H2O (0.1% TFA)/CH3CN (0.1% TFA) and collection and concentration of the appropriate fractions afforded the title product as a white solid. 1H NMR (400 MHz, d6-DMSO) δ 7.49-7.47 (m, 2H), 7.40-7.33 (m, 3H), 5.44 (br s, 1H), 5.21 (dd, J=11.2, 30.4 Hz, 2H), 4.18 (dd, J=4.8, 13.6 Hz, 1H), 3.91 (d, J=13.6 Hz, 1H), 3.80 (s, 3H), 3.01 (s, 3H); ES MS (M+H)=360.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07476666B2 |
|---|
| Source dataset | uspto-grants-2009_01 |
|---|
| ORD ID | ord-34ee6c839baa43528fb84a0d390ad7b4 |
|---|
| Source note | uspto-grants-2009_01 |
|---|